ResearcherCentre Hospitalier Universitaire de Clermont-FerrandActive in the last 2 years

A Demazière

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-1550-7580; OpenAlex author ID A5028799401. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

French multi-institutional cost-effectiveness analysis of gemcitabine plus nab-paclitaxel versus gemcitabine alone as second-line treatment in metastatic pancr… Co-author DOI 10.1177/17588359241259635 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Denis Pezet · 1 shared paper, 2024 · strength 0.21
- Paper French multi-institutional cost-effectiveness analysis of gemcitabine plus nab-paclitaxel versus gemcitabine alone as s… DOI 10.1177/17588359241259635 ↗
Johan Gagnière · 1 shared paper, 2024 · strength 0.21
- Paper French multi-institutional cost-effectiveness analysis of gemcitabine plus nab-paclitaxel versus gemcitabine alone as s… DOI 10.1177/17588359241259635 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.